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Background: In Canada, demand for multidisciplinary bariatric (obesity) care far outstrips capacity. Consequently,
prolonged wait times exist that contribute to substantial health impairments. A supportive, educational, self-
management intervention (with in-person and web-based versions) for patients wait-listed for bariatric care has
already been implemented in Northern and Central Alberta, Canada, but its effectiveness is unknown. The objective
of this trial is to evaluate the clinical and economic outcomes of two self-management programs of varying
intensity that are currently in use.
Methods: We conducted a pragmatic, prospective, parallel-arm, randomized controlled trial of 651 wait-listed
patients from two regional bariatric programs. Patients were randomized to (1) an in-person, group-based
intervention (13 sessions; n = 215) or (2) a web-based intervention (13 modules; n = 225) or (3) control group
(printed educational materials; n = 211). After randomization, subjects had 3 months to review the content
assigned to them (the intervention period) prior to bariatric clinic entry. The primary outcome was the
proportion of patients achieving 5% weight loss at 9 months. Intention-to-treat two-way comparisons were
performed and adjusted for baseline age, sex, site and body mass index.
Results: At baseline, mean age was 40.4 ± 9.8 years, mean weight was 134.7 ± 25.2 kg, mean body mass index was 47.
7 ± 7.0 kg/m2 and 83% of participants were female. A total of 463 patients (71%) completed 9 months follow-up. At
least 5% weight loss was achieved by 24.2% of those in the in-person strategy, 24.9% for the web-based strategy and
21.3% for controls (adjusted p value = 0.26 for in-person vs. controls, 0.28 for web-based vs. controls, 0.96 for in-person
vs. web-based). Absolute and relative (% of baseline) mean weight reductions were 3.7 ± 7.1 kg (2.7 ± 5.4%) for in-
person strategy, 2.8 ± 6.7 kg (2.0 ± 4.8%) for web-based and 2.9 ± 8.8 kg (1.9 ± 5.9%) for controls (p > 0.05 for all
comparisons). No between-group differences were apparent for any clinical or humanistic secondary outcomes. Total
annual costs in Canadian dollars were estimated at $477,000.00 for the in-person strategy, $9456.78 for the web-based
strategy and $2270.31 for provision of printed materials.
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Discussion: Two different self-management interventions were no more effective and were more costly than
providing printed education materials to severely obese patients. Our findings underscore the need to develop more
potent interventions and the importance of comprehensively evaluating self-management strategies before
widespread implementation.
Trial registration: ClinicalTrials.gov, NCT01860131. Registered 17 May 2013.
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Severe obesity (defined as a body mass index (BMI)
≥40 kg/m2) currently affects 8% of Americans and 3% of
Canadians and is the most rapidly growing obesity
subclass [1, 2]. Severe obesity increases the risk of type 2
diabetes mellitus by more than eightfold [3]; reduces life
expectancy by 5–13 years [4]; increases health care ex-
penditures by 50–200% [5]; and dramatically reduces
quality of life [6].
In Canada’s publicly funded, universally accessible
health care system, bariatric care for severely obese indi-
viduals is delivered primarily within a small number of
multidisciplinary bariatric specialty clinics located in
major cities [7]. Upon entry, patients receive intensive
lifestyle modification (diet, exercise, behavioural modifi-
cation) counselling; in addition, after undergoing multi-
disciplinary assessment to determine suitability, highly
selected patients undergo bariatric surgery. As a result
of the limited number of clinics and large number of
patients, demand-supply gaps for multidisciplinary bar-
iatric care exist and have resulted in protracted multi-
year wait times [8, 9]. In other countries with publicly
funded health care, such as the United Kingdom, waits
are similarly prolonged [10–12]. Although, on average,
the weight and health comorbidities of wait-listed
patients appear stable over 2 years, baseline health status
is markedly impaired compared to population norms
[13–15]. Most wait-listed patients report that waiting
contributes to physical, mental and financial deterior-
ation over time, and nearly 75% are interested in receiv-
ing supportive care as they wait [16].
To try and meet this unmet patient-centred demand,
prime wait-listed patients on the basics of weight man-
agement and better support wait-listed patients facing
protracted wait times in Alberta, Canada, Alberta Health
Services (AHS) developed a multidisciplinary, in-person,
group-based educational self-management program.
This in-person program was delivered in community
centres across Edmonton (Northern Alberta) beginning
in 2008 and expanded to other centres within the
province over the next 4–5 years. In 2012, a less costly
web-based version of the program, with similar content,
was initiated in the bariatric program in Calgary
(Southern Alberta).Prior to implementation, neither program had been
formally and rigorously evaluated in terms of effective-
ness or cost-effectiveness. Therefore, we performed a
randomized controlled trial (RCT) to evaluate the bene-
fits and costs of both the in-person and web-based pro-
grams compared to a printed educational materials
control group. Thus, the primary rationale for this trial
was to verify that scarce medical resources were being
optimally allocated and, in addition, to determine the
most efficient method of delivering self-management
support.Methods
A detailed trial protocol has been published previously
[17]. All subjects provided written informed consent.
The evaluating self-management and educational sup-
port in severely obese patients awaiting multidisciplinary
bariatric care (EVOLUTION) trial protocol was ap-
proved by the University of Alberta Research Ethics
Board (PRO00031699) and, prior to patient enrolment,
the trial was formally registered at ClinicalTrials.gov
(NCT01860131).Design
We conducted a 9-month pragmatic, prospective, RCT
enrolling consecutive, consenting patients with severe
obesity newly wait-listed for adult bariatric specialty
care. The study was conducted in Edmonton and Red
Deer (Northern and Central Alberta, respectively).
Patients were randomly assigned (1:1:1) to one of three
groups:
1. In-person, community-based self-management
2. Web-based self-management
3. A one-time provision of printed educational
materials
Computer-generated randomization was performed
centrally and independently by the EPICORE centre
(www.epicore.ualberta.ca) to ensure allocation conceal-
ment from all research personnel; randomization was
stratified by participating study centre.
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The Edmonton Weight Wise program, established in
2005, was the first large-scale, multidisciplinary bariatric
program in Alberta. Weight Wise delivers integrated,
patient-focused, evidence-based care to the Edmonton
Zone of Alberta Health Services (AHS). Treatments are
guideline-concordant and based on the Canadian obesity
guidelines [18]. This region is one of the largest inte-
grated health delivery systems in Canada, serves a catch-
ment population of 1.6 million residents and has an
annual health care budget of 2 billion dollars.
Weight Wise includes a central, region-wide, single-
point-of-access referral system. The Adult Specialty
Clinic offers intensive multidisciplinary medical/surgical
bariatric care to patients with BMI levels of ≥35 kg/m2
(estimated to be at least 125,000 individuals within the
region). Patients are referred for both medical and surgi-
cal management. About 64% of wait-listed patients are
interested in bariatric surgery, and the remainder in
medical management alone. All patients receive medical
therapy initially and for several months before evaluation
for surgery (if interested). The decision to perform sur-
gery depends, in part, on how much effort and commit-
ment the patient has put into lifestyle modification (even
if unsuccessful). Therefore, patients interested in surgery
cannot forgo medical weight loss recommendation ad-
herence because they wish to have surgery.
At the time that this trial was performed, approxi-
mately 1200 new referrals were being processed annu-
ally, and 300 bariatric surgeries were being performed.
Wait times have fluctuated and varied from as short as
4 months to as long as 30 months. Within the Weight
Wise program, nurses are case managers and are re-
sponsible for coordinating care with other health care
providers. Dieticians provide the bulk of the health be-
haviour modification counselling. This is reinforced by
other care providers (physician, sleep specialist, psych-
ologist, psychiatrist, occupational therapist, physiother-
apist and social worker), who see patients for targeted
indications within their area of specialization. The pro-
gram in Red Deer was modelled after the parent Weight
Wise program. Red Deer is a smaller centre that serves a
more rural population, with approximately 600 referrals
and 100 bariatric surgeries per year.
Interventions
In-person self-management arm
This program varied slightly over the trial period, but, at
its core, broadly consisted of 13 sessions (Additional file 1:
Table S1) delivered in a group format by a multidisciplin-
ary team at community health centres in Edmonton and
Red Deer. Each session was approximately 2.5 hours long
and was led by the appropriate content expert(s) from a
team of four registered nurses, one Canadian Society forExercise Physiology (CSEP) specialist, one MSc psycholo-
gist and one registered dietician. The program is free of
charge and has been designed to educate patients regard-
ing proper diet and exercise; improve their weight
management skills by enhancing self-management and
self-efficacy; and help them identify/overcome barriers to
success. In addition to providing supportive care to wait-
listed patients, the program is intended to prime patients
for weight management success once they begin bariatric
care. The evidence-based curriculum [18] stresses health-
ful eating; gives practical tips to increase physical activity;
teaches basic behavioural modification techniques such as
goal setting and self-monitoring; and includes strategies
for dealing with stress and maladaptive eating behaviours
such as emotional eating.
Web-based self-management arm
The web-based program was very similar in content to
the in-person intervention (Additional file 1: Table S2),
with the exception that it was delivered solely in an on-
line format. Each patient had a personalized login that
was tracked by the study team. All 13 modules were
available to the subject on a single online platform, ac-
cessible any time after randomization. Subjects were
asked to read all 13 modules (Additional file 1: Table S2)
over a 3-month period.
Control arm
Controls received a one-time provision of printed educa-
tional materials at the time of enrolment, consisting of
Canada’s Guide to Healthy Living and Canada’s Physical
Activity Guide. These materials are guideline-based,
user-friendly and visually appealing. They are produced
by the Canadian government and made available free of
charge.
Of note, both for purposes of ensuring fidelity and
maintaining some degree of ’attention control’, subjects
in all three study arms were contacted by telephone
1 week after enrolment for troubleshooting and to en-
courage them to read the printed materials, register for
in-person sessions or access the web modules.
Participants
We enrolled patients with BMI levels ≥35 kg/m2 who
were newly wait-listed for adult (age >18 years) bariatric
specialty care at the Edmonton or Red Deer clinic.
Patients with one or more of the following characteris-
tics were excluded: (1) completed more than four
Weight Wise Community Modules (web-based or group
session) in previous 3 months, (2) pregnant, (3) unable
to read/write/comprehend English, (4) unable to access
the web, (5) unable or unwilling to attend in-person ses-
sions, (6) uncontrolled severe personality disorder, active
psychosis, active substance dependence and/or major
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study investigators, (8) participated in concurrent trial
related to obesity management, (9) resided more than
1 hour driving time away from Weight Wise clinic or
(10) declined to participate.
Enrolment procedures and timelines
Consecutive, consenting, eligible patients were enrolled
between 2013 and 2015. Study participants were instructed
to not begin any other new lifestyle modification or weight
loss-related interventions during the first 3 months of the
study. Those randomized to the in-person and web-based
interventions were instructed to complete the entire
program within a 3-month period. Thereafter, all subjects,
including controls, immediately entered the bariatric clinic
and commenced multidisciplinary bariatric care. This
meant that the usual wait-listed period for entry into the
Weight Wise clinic was waived for trial participants.
Subjects were followed for an additional 6 months after
entry into the clinic. Thus, overall, the trial consisted of a
3-month period during which the interventions were ap-
plied, followed by a 6-month follow-up period, with ascer-
tainment of outcomes at baseline, 3 months, 6 months
and 9 months (see below). To prevent between-arm con-
tamination, subjects received specific information on their
assigned treatment group only. Access to the web-based
program was controlled using a hidden URL, which was
given only to participants randomized to the web-based
intervention arm, and patients in the web-based or control
groups were asked not to attend the in-person community
sessions.
Outcomes
Data collection procedures including detailed case report
forms have been published previously [17]. Although
clinic staff could not be blinded to allocation status, all
outcome assessments were performed by research assis-
tants working independently from regular clinic staff.
Data were collected at baseline and at 3, 6 and 9 months
post-randomization, with the primary analysis focusing
on 9-month outcomes.
Anthropometric
Body weight was measured using a validated, calibrated
Scale-Tronix bariatric scale and recorded to the nearest
0.1 kg, with the subject wearing light indoor clothing
with empty pockets, no shoes and an empty bladder.
Height was measured to the nearest 0.1 cm using a wall-
mounted stadiometer. Blood pressure was measured
with a Microlife Watch BP automated monitor, with
three readings taken simultaneously in each arm, the
first reading discarded and the latter two averaged. The
arm that had the highest mean blood pressure at thebaseline visit was used to calculate the 9-month blood
pressure change.
Clinical
The primary outcome was the proportion of patients
achieving 5% weight loss, considered a clinically import-
ant degree of weight loss by experts and contemporary
guidelines [18]. Absolute and relative weight loss and
BMI change were also assessed. Additional clinical
outcomes included change in blood pressure, fasting
lipids and A1c and the change in prevalence of hyperten-
sion, diabetes and dyslipidemia as previously described.
Hypertension was considered present if self-reported, if
blood pressure levels were ≥140/90 mm Hg or if antihy-
pertensive medications were prescribed. Diabetes was de-
fined based upon self-report, a baseline A1c ≥6.5% and/or
antidiabetic drug therapy. Dyslipidemia was diagnosed in
the presence of one of the following: self-report, treat-
ment with a lipid-lowering agent or an abnormality on
the baseline fasting lipid panel (low-density lipoprotein
(LDL) cholesterol ≥5.2 mmol/L, high-density lipopro-
tein (HDL) cholesterol <0.9 mmol/L or triglyceride
level ≥2.8 mmol/L).
To ensure that utilization was equivalent once patients
entered the clinic, we tracked the mean number of clinic
visits to each type of health care provider over the
follow-up period.
Humanistic
We used previously validated instruments to assess health-
related quality of life (Short Form Survey (SF-12) [19] and
EuroQol five dimensions (EQ-5D) [20]), preference-based
utilities [20], satisfaction with medical care (Patient Satis-
faction Questionnaire (PSQ) [21] scored on a 5-point
Likert scale), self-efficacy (Weight Efficacy Life-Style Ques-
tionnaire (WEL) [22], depression (Patient Health Ques-
tionnaire (PHQ-8) [23] and readiness to change (assessed
using a visual analogue scale (VAS) ranging from 0 to 10).
Resource use and costs for each study arm
The overall annual and per-patient costs of the two
interventions relative to the control group were calcu-
lated using a methodology conforming to the three-step
micro-costing technique of identification, measurement
and valuation of resources [24, 25]. Estimates of health
care professional time for creation and delivery of the in-
terventions were obtained from AHS Chronic Disease
program managers. In 2012–2013, 1707 patients were
referred to the Edmonton and Red Deer programs and
had an initial consult; for costing it was assumed that
annually 1707 patients would receive the in-person strat-
egy or the web-based strategy or be mailed printed
educational materials.
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date the materials used in the in-person and web-based
study arms as well as delivery of the in-person strategy
were determined by obtaining estimates of time required
and use of AHS wage rates for each category of staff
(nurses, dietician, exercise therapist, psychologist). The
resources to develop both the web-based and in-person
interventions consisted primarily of the health care
professional time required for literature review, summar-
izing the content and preparation of the content for de-
livery. The one-time development cost was amortized
over a 5-year period. For the in-person strategy, a regis-
tered dietician and registered nurse performed the bulk
of the work, with smaller contributions from an exercise
specialist and a psychologist. No overhead costs were
assigned to the in-person strategy, as sessions were
conducted in health care facilities at off-peak hours. A
registered dietician developed the web-based modules.
Further, both the in-person sessions and web-based
modules were updated every 2 years; therefore, the
health care professional time required for this work was
estimated and included in the overall costs. Finally, the
costs of delivering content, including generating patient
lists and mailing out instructions in the web-based
group as well as hosting and delivering in-person ses-
sions, were estimated. Current wage rates in Alberta,
Canada for each type of health care professional deliver-
ing content were used. Hourly wage rate assumptions
were $42.62 for a registered dietician, $42.62 for a regis-
tered nurse, $44.44 for an exercise specialist and $46.88
for a psychologist.
Resources required for the control arm included
patient list generation, administrative work required to
prepare and address the envelopes and mailing costs
[26]. Costs associated with development of the materials
were not included; the mailed literature (Canada’s Food
Guide) is provided free of cost by Health Canada.
All costs are reported in 2013 Canadian dollars.
Statistical analyses
Descriptive analyses were performed including calculation
of means, medians and standard deviations (SDs). Baseline
variables were compared between the three study
groups using one-way analysis of variance (ANOVA)
for continuous outcomes and chi-squared tests for
dichotomous ones.
Between-group change scores were compared using
multivariable logistic regression for dichotomous vari-
ables (including the primary) and linear regression for
continuous outcomes, adjusting for age, sex, site and
baseline BMI. An intention-to-treat analysis was per-
formed using a baseline-observation-carried-forward ap-
proach, designated a priori [17], for the primary analysis.
A completers analysis, limited to those participants withfull baseline and 9-month data, was also reported for
weight and BMI-based outcomes. Multiple imputation
was not performed because the data were not missing
completely at random [27]. The primary outcome com-
parisons of interest were between the in-person strategy
and controls and the online strategy and controls. Subse-
quently, the in-person and online interventions were
then compared.
One-way ANOVA was used to compare health care
provider visit frequency and costs across study arms,
with t tests used to compare between-study arms if sig-
nificant differences were found. We considered p values
less than 0.05 statistically significant. No adjustment for
multiple testing was performed [28]. All analyses were
performed using SAS® (Version 9.3, Cary, NC, USA).
Sample size estimate
The study was powered to detect a 15% difference be-
tween the two interventions and controls in the propor-
tion of 5% weight responders with an alpha level of 0.05
and a power of 0.90. We assumed that the control arm
would result in a 5% weight loss in 20% of subjects (i.e.
the control event rate = 20% at one year) [29]. The initial
sample size estimate was for ~180 patients per arm or
540 patients total. This was adjusted upwards to account
for potential attrition and permit secondary and sub-
group analyses to arrive at the final sample size.
Results
Of 2416 patients contacted, 1765 (73%) were excluded
(Fig. 1). The primary reason for exclusion was that
the patient did not reside in the study locality (within
a 1-hour drive; n = 1433 (59%)). In total, 651 patients
were enrolled and randomized to the in-person strat-
egy (n = 215), web-based strategy (n = 225) or the
control arm (n = 211).
Baseline characteristics
Baseline characteristics are summarized in Table 1. In
the overall study sample, mean age was 40.4 ± 9.8 years,
mean weight was 134.7 ± 25.2 kg, mean BMI was 47.7 ±
7.0 kg/m2 and 83% of participants were female. There
were few clinically meaningful differences across study
arms (Table 1).
Follow-up and attendance to the interventions
Follow-up to 9 months was completed in 463 partici-
pants (71%). Of the 188 patients (29%) who withdrew
early, 68 no longer wished to participate in the study, 94
were lost to follow-up and 26 left for other reasons. No
deaths occurred during the study period. Early with-
drawal occurred in 69 patients (32%) randomized to the
in-person strategy, 59 patients (26%) randomized to the
web-based strategy and 60 patients (28%) randomized to
Fig. 1 Study overview
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visit frequency over the follow-up period were apparent
across study arms after randomization (Additional file 1:
Table S3; p > 0.05 for all comparisons).
Within the 3-month window, 75% of subjects assigned
to the in-person strategy attended at least one session,
with 62% attending three or more sessions. The mean
number of attended in-person sessions was 5.3 ± 4.1.
One patient randomized to each of the web-based or
control arms reported attending an in-person session.
For subjects assigned to the web-based strategy, 86%
completed at least one module, 80% completed three or
more modules and the mean number of completed mod-
ules was 9.2 ± 4.9. No subjects assigned to the in-person
or control arms reported viewing a web-based module.
Weight and BMI changes
Anthropometric outcomes are summarized in Table 2.
The proportion of patients achieving 5% weight loss was
24.2% for the in-person strategy, 24.9% for the web-based
strategy and 21.3% in controls (adjusted p value = 0.26 for
in-person vs. controls, 0.28 for web-based vs. controls,
0.96 for in-person vs. web-based). Absolute and relative
(% of baseline) mean weight reductions were 3.7 ±
7.1 kg (2.7 ± 5.4%) for the in-person strategy (n = 215),
2.8 ± 6.7 kg (2.0 ± 4.8%) for the web-based strategyand 2.9 ± 8.8 kg (1.9 ± 5.9%) for controls (p > 0.05 for
all comparisons).
Results of the completers sensitivity analyses were
broadly consistent with the primary analysis, with no
statistically significant differences between study arms
for the primary endpoint (Table 2). Percent weight loss
was slightly greater in patients receiving the in-person
intervention relative to controls (4.2% vs. 2.7%; adjusted
p = 0.046). Absolute weight loss, relative weight loss and
BMI reductions were modestly, but statistically signifi-
cantly, higher in the in-person arm relative to the web-
based strategy (Table 2).
Secondary clinical and humanistic endpoints
No clinically important or statistically significant differ-
ences in any of the secondary endpoints were observed
between study arms (Table 3).
Costs
In-person strategy
A total time of 535 hours was required for initial de-
velopment of the in-person strategy content, at a total
cost of $23,128. Two-year content updates required
an additional 125 hours, accruing a cost of $10,998
for each update cycle. Delivery of each session took
approximately 4 hours of health care professional
Table 1 Baseline characteristics
Variable Overall n = 651 In-person n = 215 Web-based n = 225 Controls n = 211 p value (among groups)*
Age (years, mean ± SD) 40.4 ± 9.8 40.5 ± 9.9 40.6 ± 10.1 40.4 ± 9.3 0.9
Weight (kg, mean ± SD) 134.7 ± 25.2 131.1 ± 25.9 134.4 ± 23.5 138.8 ± 25.8 0.01
BMI (kg/m2 ± SD) 47.7 ± 7.0 46.7 ± 7.4 47.7 ± 6.6 48.7 ± 7.2 0.01
Sex (Females, %) 540 (83) 176 (81) 183 (81) 181 (86) 0.4
White race (%) 594 (91) 195 (90) 205 (91) 194 (92) 0.9
Education, no. (%)
Some high school or less 52 (7.9) 19 (8.8) 19 (8.4) 14 (6.6)
High school diploma 110 (16.9) 29 (13.5) 43 (19.1) 38 (18.0)
Some post-secondary 118 (18.1) 38 (17.7) 38 (16.9) 42 (19.9)
Completed post-secondary 369 (56.7) 129 (60) 123 (54.7) 117 (55.5) 0.4
Smoking status, no. (%)
Current smoker 84 (12.9) 25 (11.6) 33 (14.7) 26 (12.3)
Former smoker 143 (22.0) 47 (21.9) 49 (21.8) 47 (22.3)
Never smoker 424 (65.1) 143 (66.5) 143 (63.6) 138 (65.4) 0.9
Medical comorbidities, no. (%)
Hypertension 346 (53.2) 106 (49.3) 113 (50.2) 127 (60.2) 0.04
Diabetes 162 (24.9) 52 (24.2) 61 (27.1) 49 (23.2) 0.6
Dyslipidemia 274 (42.1) 91 (42.3) 92 (40.4) 92 (43.6) 0.8
Sleep apnea 180 (27.7) 53 (24.7) 78 (34.7) 49 (23.2) 0.01
Cardiovascular event 15 (2.3) 3 (1.4) 6 (2.7) 6 (2.8) 0.5
Mental illness 319 (49.0) 103 (47.9) 105 (46.7) 111 (52.6) 0.4
Clinical measurements, mean ± SD
Systolic BP (mmHg) (n = 568) 136.1 ± (17.1) 135.4 ± (15.1) 134.0 ± (14.9) 139.0 ± (20.5) 0.01
Diastolic BP (mmHg) (n = 569) 82.5 ± 12.5 81.6 ± 10.6 81.5 ± 11.3 84.3 ± 14.8 0.05
Total cholesterol (mmol/L) (n = 586) 4.7 ± 0.9 4.7 ± 0.9 4.8 ± 0.9 4.7 ± 1.0 0.9
HDL cholesterol (mmol/L) (n = 586) 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 0.2
LDL cholesterol (mmol/L) (n = 576) 2.7 ± 0.8 2.7 ± 0.8 2.7 ± 0.8 2.7 ± 0.8 1.0
Triglycerides (mmol/L) (n = 586) 1.8 ± 0.9 1.8 ± 1.0 1.8 ± 0.9 1.7 ± 0.8 0.9
A1c (%) (n = 573) 6.0 ± 1.2 6.0 ± 1.1 6.0 ± 1.4 5.9 ± 1.1 0.7
EQ-5D VAS score 53.1 ± 18.9 54.3 ± 18.4 54.6 ± 18.6 50.3 ± 19.5 0.03
EQ-5D index score 0.84 ± 0.06 0.83 ± 0.06 0.84 ± 0.06 0.84 ± 0.06 0.33
SF-12 PC score 37.5 ± 8.8 38.0 ± 8.9 37.3 ± 8.7 37.2 ± 9.0 0.58
SF-12 MC score 39.9 ± 9.6 40.6 ± 9.6 40.2 ± 9.6 39.0 ± 9.7 0.24
WEL score 109.5 ± 35.4 108.3 ± 36.2 114.9 ± 33.2 104.9 ± 36.0 0.01
Readiness-to-change score 9.0 ± 1.1 8.9 ± 1.1 9.0 ± 1.1 8.9 ± 1.2 0.58
PHQ-8 score 17.4 ± 5.5 17.4 ± 5.4 17.1 ± 5.6 17.7 ± 5.4 0.58
*Using ANOVA for continuous variables and chi-square for dichotomous variables
MC mental component, PC physical component
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0.5 hour of pre-session preparation and post-session
question-and-answer time and 1 hour of travel time.
Although in-person sessions had a maximum capacity
of 22 patients, they were delivered, on average, to 8.2
patients. The total annual cost of delivery of a fullcycle of the in-person intervention (all 13 sessions
each at 4 hours) was $2241.
Per-patient development and update costs were esti-
mated at $2.71 and $3.22, respectively. Assuming 8.2
patients attend each set of modules, the per-patient cost
of delivery of the in-person strategy was $273.40. The
Table 2 Changes in weight and BMI
Outcome In-person Web-based Controls In-person minus
controls (95% CI)
p value* Web-based minus
controls (95% CI)




n = 215 n = 225 n = 211
5% weight loss responders, % 24.2 24.9 21.3 2.9 (-5.1 to 10.9) 0.26 3.6 (-4.4 to 11.5) 0.28 -0.7 (-8.7 to 7.3) 0.96
Absolute weight change, kg ± SD -3.7 ± 7.1 -2.8 ± 6.7 -2.9 ± 8.8 -0.8 (-2.3 to 0.8) 0.16 0.2 (-1.3 to 1.6) 0.96 -0.9 (-2.2 to 0.4) 0.11
Percent weight change, % ± SD -2.7 ± 5.4 -2.0 ± 4.8 -1.9 ± 5.9 -0.9 (-1.9 to 0.2) 0.08 -0.1 (-1.1 to 0.93) 0.79 -0.8 (-1.7 to 0.2) 0.09
BMI change, kg/m2 ± SD -1.3 ± 2.5 -1.0 ± 2.4 -1.0 ± 3.0 -0.3 (-0.8 to 0.2) 0.13 0 (-0.5 to 0.5) 0.88 -0.3 (-0.8 to 0.1) 0.12
Completers analysis
n = 141 n = 164 n = 149
5% weight loss responders, % 36.9 34.2 30.2 6.7 (-4.2 to 17.6) 0.13 3.9 (-6.4 to 14.3) 0.33 2.7 (-8.1 to 1.4) 0.58
Absolute weight, kg ± SD -5.6 ± 8.2 -3.8 ± 7.6 -4.2 ± 10.2 -1.4 (-3.6 to 0.7) 0.13 0.4 (-1.6 to 2.3) 0.88 -1.8 (-3.6 to -0.06) 0.04
Percent weight change, % ± SD -4.2 ± 6.2 -2.7 ± 5.4 -2.7 ± 6.8 -1.5 (-3.0 to -0.01) 0.046 0 (-1.4 to 1.4) 0.86 -1.5 (-2.8 to -0.2) 0.02
BMI change, kg/m2 ± SD -2.0 ± 2.8 -1.4 ± 2.7 -1.4 ± 3.5 -0.6 (-1.3 to 0.1) 0.08 0.1 (-0.6 to 0.7) 0.92 -0.6 (-1.3 to -0.01) 0.04
*Adjusted for baseline age, sex and baseline BMI using logistic or linear regression
CI confidence interval, SD standard deviation, BMI body mass index
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total annual cost was $476,816.31.
Web-based strategy
An estimated 403 hours of registered dietician’s time
was required for web-based module development, with a
total cost of $17,175. Estimated costs for 2-year updates
were $8072 for an additional 189 hours of work. Annual
web hosting and information technology support costs
were estimated at $2000.
For 1707 patients, per-person costs for initial develop-
ment, update and hosting were $2.01, $2.36 and $1.17,
respectively, and the overall web-based strategy averageTable 3 Changes in secondary endpoints
Outcome Sample size In-person Web-based Controls In
co
Systolic BP (mm Hg) 568 -2.2 ± 10.0 -0.7 ± 10.3 -2.6 ± 15.4 0.
Diastolic BP (mm Hg) 569 -1.1 ± 8.6 -1.6 ± 8.6 -1.9 ± 11.8 0.
Total cholesterol (mmol/L) 586 -0.1 ± 0.7 -0.1 ± 0.6 -0.2 ± 0.6 0.
HDL cholesterol (mmol/L) 586 0.01 ± 0.14 0.01 ± 0.16 -0.01 ± 0.13 0.
LDL cholesterol (mmol/L) 576 -0.1 ± 0.4 -0.05 ± 0.4 -0.09 ± 0.4 -0
Triglycerides (mmol/L) 586 1.8 ± 1.0 1.8 ± 0.9 1.7 ± 0.8 0.
A1c (%) 573 -0.10 ± 0.40 -0.16 ± 0.80 -0.11 ± 0.50 0.
EQ-5D VAS score 647 10.3 ± 15.7 11.4 ± 17.3 11.0 ± 17.8 0.
EQ-5D index score 645 0.03 ± 0.05 0.02 ± 0.04 0.02 ± 0.05 0.
SF-12 PC score 639 4.1 ± 7.3 4.9 ± 6.7 3.7 ± 7.2 0.
SF-12 MC score 639 4.2 ± 8.1 4.1 ± 7.4 4.7 ± 8.8 -0
WEL score 649 22.3 ± 31.2 20.8 ± 29.7 22.2 ± 34.6 0.
Readiness-to-change score 650 -0.08 ± 1.19 -0.14 ± 1.10 -0.07 ± 1.30 0.
PHQ-8 score 632 -2.8 ± 4.4 -3.1 ± 4.2 -3.1 ± 4.8 0.
Numbers are mean ± SD. Baseline-observation-carried-forward imputation
*Adjusted for baseline age, sex and baseline BMI using logistic or linear regression
BP blood pressure, CI confidence interval, EQ EuroQol, HDL high-density lipoprotein, LDL
Patient Health Questionnaire, SD standard deviation, SF Short Form, VAS visual analogueper-patient cost was $5.54. The total annual cost of this
strategy was $9456.78.Controls
The estimated per-person cost for mailing the printed
educational materials was $1.33 per person, with a total
annual cost of $2270.31.Costs of each intervention relative to controls
Relative to the control arm, the per-patient incremental
cost was $278 for the in-person strategy and $274 for




p value* In-person minus
web-based
p value*
4 ± 12.9 0.79 1.8 ± 13.0 0.20 -1.4 ± 10.1 0.17
8 ± 10.3 0.56 0.3 ± 10.3 0.82 0.5 ± 8.6 0.57
1 ± 0.6 0.20 0.02 ± 0.7 0.86 0.1 ± 0.6 0.19
02 ± 0.13 0.11 0.02 ± 0.14 0.18 0.003 ± 0.15 0.8
.01 ± 0.4 0.77 0.04 ± 0.4 0.34 -0.05 ± 0.4 0.24
04 ± 0.55 0.50 0.05 ± 0.58 0.38 0.1 ± 0.7 0.15
01 ± 0.45 0.79 -0.05 ± 0.64 0.54 0.06 ± 0.63 0.38
7 ± 16.8 0.74 0.4 ± 17.5 0.92 -1.0 ± 16.6 0.52
01 ± 0.05 0.11 0.001 ± 0.05 0.88 0.006 0.15
3 ± 7.2 0.63 1.2 ± 6.9 0.08 -0.9 ± 7.0 0.21
.5 ± 8.5 0.67 -0.6 ± 8.1 0.48 0.06 ± 7.8 0.99
1 ± 32.9 0.90 -1.4 ± 32.1 0.59 1.5 ± 30.4 0.58
003 ± 1.30 0.95 0.06 ± 1.20 0.64 0.06 ± 1.13 0.54
3 ± 4.6 0.63 0.04 ± 4.5 0.93 0.3 ± 4.3 0.54
low-density lipoprotein, MC mental component, PC physical component, PHQ
scale, WEL Weight Efficacy Lifestyle questionnaire
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the web-based strategy.
Discussion
To summarize, in this randomized controlled trial of more
than 600 severely obese patients enrolled in a large Canadian
bariatric program, more intensive self-management support
interventions, delivered either in-person or online, were no
more effective (and yet more costly) than a one-time inter-
vention that consisted of providing printed educational mate-
rials to patients. In particular, in the primary analysis, neither
active intervention effectively reduced weight, optimized
cardio-metabolic parameters or improved humanistic end-
points compared with controls. Although some statistically
significant differences were found between study arms in the
completers analysis, these were modest, subject to confound-
ing by healthy adherer effects, would not be considered clin-
ically important and were of marginal significance given that
we did not adjust for multiple testing.
In aggregate, the patients in our trial had substantially
impaired physical and mental health, poor self-efficacy
and (according to the PHQ-8) on average had symptoms
consistent with major depression. These self-management
strategies were developed to mitigate this degree of suffer-
ing, improve health and quality of life, help patients cope
with extended bariatric wait times and ready patients for
more intensive medical and surgical multidisciplinary care
[17]. Our findings indicate that these strategies are not
effective and, thus, alternative methods of supporting
these patients will need to be considered (but should also
be rigorously evaluated to ensure that they are worthwhile
prior to implementation).
In terms of the broader literature, a recent systematic
review of reviews examining the effectiveness of self-
directed interventions for weight loss, whether web-based
or conventional, judged only 7 of 20 reviews to be of high
quality [30]. Even when statistically significant reductions in
weight were found, the degree of weight loss was very mod-
est (e.g. 1.5 kg) and of a clinically unimportant magnitude
[31], with few reviews linking intervention content to
effectiveness. Similarly, a recent systematic review and
meta-analysis of 84 studies examining e-Health interven-
tions reported very modest weight loss compared to
minimal intervention controls (mean incremental weight
reduction of 1.40 kg (95% CI 0.82–1.98)) [32]. Furthermore,
an 818-patient recent cluster randomized controlled trial
done in 56 primary care practices England found that in-
person and web-based interventions were only minimally
effective, producing statistically significant (but by our pre-
specified trial criteria, clinically inconsequential) [17] weight
reductions of only 1.5 and 1.3 kg, respectively, relative to
the control intervention consisting of generic, brief, struc-
tured dietary modification advice [33]. In aggregate, these
results are similar to our findings and suggest that theeffectiveness of more intensive self-management interven-
tions, whether delivered in a web-based or in-person for-
mat, is likely to be limited relative to providing simple and
standardized printed educational materials to patients. One
important difference between this study and prior trials is
that we conducted a pragmatic evaluation of interventions
that have been implemented and are currently in use in
clinical practice; thus, our results depict a more realistic
assessment of what can be expected outside of a highly
selected clinical trial sample.
Strengths of this study include its pragmatic comparative
effectiveness approach, its randomized design and its
assessment of a broad range of endpoints important to
patients, providers and decision makers. There are also sev-
eral limitations. First, nearly 30% of individuals withdrew
early, which is a common finding in trials enrolling
subjects with severe obesity and thus not unexpected
[34, 35]. Accordingly, we employed a conservative
baseline-observation-carried forward approach, chosen
a priori, for the primary analysis. In addition, for weight-
related outcomes, we reported a less conservative on-
treatment analysis, and these results were very similar to
those of the primary analysis, demonstrating that our find-
ings were robust relative to the type of analytic strategy
used. Second, we examined a population with severe obes-
ity being considered for bariatric surgery, and our results
may have been different if we had examined a primary
care population with lesser degrees of obesity. Third, pa-
tients assigned to web-based modules may have logged in
but not reviewed the content, limiting effectiveness.
Fourth, there may be concerns related to external validity,
with our results most specific to the Northern and Central
Alberta multidisciplinary bariatric specialty care programs.
That said, the populations studied and the types of
programs evaluated should be generalizable to many other
Canadian bariatric programs, particularly because many
of these programs were based on the Edmonton Weight
Wise model [17]. By the same token, further generalization
to similar publicly funded programs in other countries
may be reasonable but should be made with caution. In
fact, our findings suggest it is important to undertake
rigorous evaluation before widespread adoption, as our
experience (and that of others) [36] suggests that ’de-im-
plementation’ is extremely difficult.
Conclusion
In conclusion, the EVOLUTION trial demonstrated that
more intensive and costly in-person or web-based self-
management interventions were no more effective than
the provision of printed educational materials for pa-
tients with severe obesity. Given these findings and the
perpetual scarcity of health care funds, we believe the
resources currently used to deliver in-person and web-
based programs should be redeployed towards
Padwal et al. BMC Medicine  (2017) 15:46 Page 10 of 11developing (and testing) more effective interventions ra-
ther than maintaining the status quo.
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